41 patients enrolled ! 40 sites activated! ongoing discussions with additional 13 U.S. sites. LEVO-CTS trial is moving and accelerating! Today, Tenax announced that the Company has currently enrolled 41 patients in the LEVO-CTS trial, and has 40 clinical sites activated with an additional 8 sites where contract negotiations have been completed. The Company also disclosed that it has discussions ongoing with an additional 13 U.S. sites.
News 
Market Data 
Discover 
